A key advance in the field has been the recognition that heterozygous (and, less commonly, homozygous) mutations in the GBA1 gene—which encodes the lysosomal enzyme glucocerebrosidase (GCase)—represent one of the most common known genetic risk factors for PD and DLB [2,3]. Here, GBA1 is linked to Lewy body dementia.